IL-2, its receptors, and bcl-2 an bax genes in normal hyperplastic and carcinomatous human prostates: Immunohistochemical comparative analysis

Growth Factors

Volumn 18, Issue 2, 2000, Pages 135-146

  Royuela, M ^a   De Miguel, M P ^a   Bethencourt, F R ^a   Fraile, B ^a   Arenas, M I ^a   Paniagua, R ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Bax; Bcl 2; Benign prostatic hyperplasia; Human prostate; IL 2; IL 2 receptors; Prostatic carcinoma

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; SAMPLE; STROMA CELL; WESTERN BLOTTING;

EID: 0033805413     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977190009003239     Document Type: Article

References (33)

1. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
2. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate
3. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not gene expression
4. Relation between bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer
5. The association of benign prostatic hyperplasia and cancer of the prostate
6. Prognostic significance of bcl-2 in clinically localized prostate cancer
7. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers
8. Immunohistochemical comparative analysis of transforming growth factor α, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates
9. Immunoexpression of tumor necrosis factor-α and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplastic and carcinomatous human prostate
10. The human interleukin-2 receptor: Analysis of structure and function
11. Expression of bcl-2, bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: Relationship with apoptosis and proliferation
12. Expression of lectin, interleukin-2 and histopathologic blood group binding sites in prostate cancer and its correlation with integrated optical density and syntactic structure analysis
13. Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1 expression in prostate cancer
14. Investigation of the subcellular distribution of the bcl-e oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
15. Apoptotic versus proliferative activities in human benign prostatic hyperplasia
16. Immunocytokines: A promising approach to cancer immunotherapy
17. Salvage immunotherapy with subcutaneous recombinant interleukin 2 (rIL-2) and alpha-interferon (A-IFN) for stage D3 prostate carcinoma failing second-line hormonal treatment
18. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies
19. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer
20. Cytokine levels in seminal plasma
21. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
22. Association of p56(lck) with IL-2 receptor β chain is critical for the Il-2-induced activation of p56(lck)
23. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
24. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
25. Application of the mononuclear antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma
26. Bcl-2 and the regulation of programmed cell death
27. Interferon-γ and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: Parallelism with c-myc and p53 expression
28. Dissociation of cytokine signals for proliferation and apoptosis
29. Apoptosis. Basic concepts and potential significance in human cancer
30. Cloning of the γ chain of the human IL-2 receptor
31. Interleukin 2 and its receptors: Recent advances and new immunological functions
32. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model
33. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview